Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis-Reference-Cited by-同舟云学术

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

Published:2021-06-25 Issue:12 Volume:80 Page:1635-1638
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Bugatti Serena^ORCID,De Stefano Ludovico,Balduzzi Silvia,Greco Maria Immacolata,Luvaro Terenzj,Cassaniti Irene,Bogliolo Laura,Mazzucchelli Iolanda,D’Onofrio Bernardo,di Lernia Michele,Mauric Eleonora,Lilleri Daniele,Baldanti Fausto,Manzo Antonio,Montecucco Carlomaurizio^ORCID

Funder

Fondazione IRCCS Policlinico San Matteo

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference6 articles.

1. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

2. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

3. American College of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 1;Curtis;Arthritis Rheumatol,2021

4. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases

5. Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases;JCI Insight;2024-06-04

2. Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases;Journal of Family Medicine and Primary Care;2024-05

3. Methotrexate and immunogenicity of vaccines in patients with rheumatic diseases;Rheumatology Science and Practice;2024-04-29

4. Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study;Vaccine;2024-02

5. Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis;npj Vaccines;2024-01-30